Alterity Therapeutics (ATHE) EBIAT (2016 - 2024)
Alterity Therapeutics (ATHE) recorded quarterly EBIAT of -$12.8 million in Q2 2024, down 36.64% quarter-over-quarter from -$9.3 million in Q2 2023, and down 36.64% on a YoY basis from -$20.1 million in Q3 2023.
Alterity Therapeutics (ATHE) EBIAT (2016 - 2024) Analysis & Trends
Alterity Therapeutics' EBIAT history runs 8 years deep, the most recent figure standing at -$12.8 million for Q2 2024.
- In Q2 2024, EBIAT fell 36.64% year-over-year to -$12.8 million; the TTM figure through Jun 2024 stood at -$38.0 million (down 30.58% YoY), while the FY2025 annual figure was -$7.8 million, up 39.01% from the prior year.
- EBIAT was -$12.8 million for Q2 2024 at Alterity Therapeutics, down from -$9.3 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$6.6 million in Q2 2020 to a low of -$12.8 million in Q2 2024.
- Historically, EBIAT has averaged -$9.5 million across 4 years, with a median of -$9.3 million in 2022.
- The sharpest annual moves came in 2020 and 2024: EBIAT rose 23.71% in 2020, then tumbled 36.64% in 2024.
- A 4-year view of EBIAT shows it stood at -$6.6 million in 2020, then tumbled by 41.44% to -$9.3 million in 2022, then slipped by 0.1% to -$9.3 million in 2023, then sank by 36.64% to -$12.8 million in 2024.
- The last three EBIAT figures came in at -$12.8 million (Q2 2024), -$9.3 million (Q2 2023), and -$9.3 million (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | 727.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -12.76 Mn |
| Jun 30, 2023 | -9.34 Mn |
| Jun 30, 2022 | -9.33 Mn |
| Jun 30, 2020 | -6.59 Mn |
| Dec 31, 2019 | -3.85 Mn |
| Jun 30, 2019 | -8.64 Mn |
| Dec 31, 2018 | 3.83 Mn |
| Jun 30, 2018 | -62,574.68 |
| Dec 31, 2017 | 2.78 Mn |
| Jun 30, 2017 | -5.67 Mn |
| Dec 31, 2016 | 2.74 Mn |
| Jun 30, 2016 | -5.77 Mn |